Definition of Disease-Progression Risk Stratification in Untreated Chronic Lymphocytic Leukemia Using Combined Clinical, Molecular and Virological Variables

Hematological Oncology - United Kingdom
doi 10.1002/hon.2439_145
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Definition of Disease-Risk Stratification Groups in Childhood Medulloblastoma Using Combined Clinical, Pathologic, and Molecular Variables

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2011English

Biologic and Clinical Significance of Molecular Profiling in Chronic Lymphocytic Leukemia

Blood Reviews
OncologyHematology
2010English

Externally Validated Predictive Clinical Model for Untreated Del(17p13.1) Chronic Lymphocytic Leukemia Patients

American Journal of Hematology
Hematology
2015English

Role of microRNA in Chronic Lymphocytic Leukemia Onset and Progression

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2015English

Cost of Disease Progression in Patients With Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Non‐Hodgkin's Lymphoma

Oncologist
Cancer ResearchMedicineOncology
2019English

Gene Expression Profile and Genomic Changes in Disease Progression of Early-Stage Chronic Lymphocytic Leukemia

Haematologica
Hematology
2008English

Clinical Pathways in Chronic Lymphocytic Leukemia: Challenges and Solutions

American Journal of Hematology
Hematology
2016English

Phase 1b Study of Venetoclax-Obinutuzumab in Previously Untreated and Relapsed/Refractory Chronic Lymphocytic Leukemia

Blood
BiochemistryImmunologyCell BiologyHematology
2019English

The Pattern of CD38 Expression Defines a Distinct Subset of Chronic Lymphocytic Leukemia (CLL) Patients at Risk of Disease Progression

Blood
BiochemistryImmunologyCell BiologyHematology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy